Know Labs (KNWN) and Its Peers Head to Head Review

Know Labs (OTCMKTS:KNWN – Get Rating) is one of 28 public companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it contrast to its peers? We will compare Know Labs to related companies based on the strength of its dividends, analyst recommendations, risk, valuation, profitability, earnings and institutional ownership.

Analyst Ratings

This is a breakdown of recent recommendations for Know Labs and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Know Labs	0	0	1	0	3.00
Know Labs Competitors	154	684	949	28	2.47

Know Labs presently has a consensus price target of $7.00, suggesting a potential upside of 340.25%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 28.72%. Given Know Labs’ stronger consensus rating and higher probable upside, analysts clearly believe Know Labs is more favorable than its peers.

Earnings and Valuation

This table compares Know Labs and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Know Labs	$120,000.00	-$25.36 million	-1.99
Know Labs Competitors	$2.66 billion	$435.24 million	9.77

Know Labs’ peers have higher revenue and earnings than Know Labs. Know Labs is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Know Labs has a beta of 3.04, suggesting that its share price is 204% more volatile than the S&P 500. Comparatively, Know Labs’ peers have a beta of 1.03, suggesting that their average share price is 3% more volatile than the S&P 500.

Insider and Institutional Ownership

10.6% of Know Labs shares are owned by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by institutional investors. 44.0% of Know Labs shares are owned by company insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Know Labs and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Know Labs	N/A	-883.81%	-176.18%
Know Labs Competitors	-3,288.15%	5.20%	2.16%

Summary

Know Labs peers beat Know Labs on 7 of the 13 factors compared.

About Know Labs (Get Rating)

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Want More Great Investing Ideas?